WE ARE SANOBIOTEC

The Global Experts in
Minor Cannabinoids

Unlock the true potential of cannabinoids
(with a little help from the experts…)
Contact UsBook a CallWatch Now
A highly driven team dedicated to the research, development and production of the highest quality minor cannabinoids.

Minor cannabinoids present a real opportunity for companies to:

  • Enhance the positive effects of products – research & development are accelerating all the time, with new and exciting findings on a regular basis.
  • Stand out from competitors – grab hold of some real brand identity by marking yourself out as pioneers in the world of cannabinoids.
  • Increase customer satisfaction and encourage loyalty – when they know your brand, values, and approach, their loyalty matches their enthusiasm.
  • Create a competitive edge by leading the pack. Don’t wait around for other companies to take the lead with minor cannabinoids. The opportunity is there right now!

ABOUT US

Cannabinoids are now well established within the pharmaceutical, cosmetics and wellness industries.
The broad and increasing range of applications for cannabinoids requires careful research and development…
…and that’s where we come in.
Sanobiotec is committed to cannabinoid research that makes a difference. Our portfolio includes both mainstream and rare cannabinoids, including the sought after CBN, CBC and CBDV.

Meet Our Team

OUR WORK

Cannabinoids, though growing in their usage, are still full of untapped potential and possibilities.
This excites everyone at Sanobiotec, as we are absolutely fascinated with cannabinoids in all their forms.
At long last, minor cannabinoids in particular are gaining well deserved attention and the research of these compounds is accelerating all the time.
With new research comes new applications, and we are developing partnerships with leading scientific organisations to hone in on this group of products and expand our R&D capabilities.

Our R&D projects

OUR QUALITY

Quality is everything.

We produce cannabinoids with quality as the core value, with quality control measures ranging from in-house testing to third party accredited lab testing.
This commitment stretches all the way through the production process and adheres to European Pharmacopeia and ISO standards.
It’s about more than simply adhering to regulations though; we do this because we care about the quality of our products.
We guarantee transparency and traceability throughout our production process and we ensure the highest quality in minor cannabinoid production and control as well.
All of this helps us provide top quality minor cannabinoids for top quality products, every single time.
Quality is our core value, built into our processes from the very beginning all the way through to the end.

Contact Us

Learn more about us from this video

Watch now

OUR NEWS

Minor Cannabinoids for Consumer Products Utilising Chemical Synthesis to Create Cannabis Compounds

Minor Cannabinoids for Consumer Products Utilising Chemical Synthesis to Create Cannabis Compounds

Tomas Kunstmonas, Head of Development at Sanobiotec, discusses the perspectives of rare cannabinoids, chemical synthesis advantages, and many other questions related to minor cannabinoids.... read more →
20/12/2021
THC level restored to 0.3% in the EU

THC level restored to 0.3% in the EU

The new policy has been adopted in Europe that will allow a maximum THC level on the field of 0.3%. This will enter into force on January 1st, 2023.... read more →
09/12/2021
Sanobiotec participated in a trade mission in Switzerland

Sanobiotec participated in a trade mission in Switzerland

On November 3, Rytis V. Urbonas, co-founder of Sanobiotec, participated in a trade mission in Basel, Switzerland on Life sciences partnership opportunities: Innovative ecosystem co-creation with Lithuanian leaders. ... read more →
09/11/2021
Visit of Lithuanian Minister of the Economy and Innovation at Sanobiotec

Visit of Lithuanian Minister of the Economy and Innovation at Sanobiotec

On September 24th, the Minister of the Economy and Innovation of the Republic of Lithuania, Aušrinė Armonaitė together with her team visited Sanobiotec. The meeting took place at Sanobiotec laboratory and HQ in Vilnius, Lithuania. ... read more →
27/09/2021
Sanobiotec will exhibit at the White Label World Expo Europe, Frankfurt

Sanobiotec will exhibit at the White Label World Expo Europe, Frankfurt

Sanobiotec will participate in this year’s WHITE LABEL WORLD EXPO EUROPE, the international trade fair for thousands of the world's top suppliers, held on October 13-14 at the Messe Frankfurt, Germany. ... read more →
09/09/2021
Announcing the launch of our newly refreshed website

Announcing the launch of our newly refreshed website

The updated site gives you more insights on minor cannabinoids and why we believe that these compounds have the potential to create value for our partners and the power to positively affect the lives of countless people around the world. ... read more →
08/09/2021